FDA Pushes For Development Of Generic Insulin.

reported that on Friday, Food and Drug Administration Commissioner Scott Gottlieb announced the FDA “will add insulin, a life-saving drug used by millions of diabetics, to its campaign to add generic competitors to brand-name products the agency believes are part of the US’s medical cost problem.” In a statement, Gottlieb said, “It’s important that we provide tools and resources to help companies to identify products on the market that lack competition.” https://www.bloomberg.com/news/articles/2017-12-15/fda-targets-insulin-for-increased-competition-to-lower-prices